Document is current
Any future updates will be listed below
-
Authors
Weymann, Deirdre
Chan, Brandon
Regier, Dean A.
- License Information
-
More Information
Article History
Received: 7 December 2022
Accepted: 21 July 2023
First Online: 9 August 2023
Declarations
:
: No human subjects and no patient-level data were used in this study. All data were simulated using the described Monte Carlo simulation framework, and generated at BC Cancer in Vancouver, Canada. In accordance with institutional policy at the University of British Columbia and BC Cancer, ethics review was not required and patient consent was not applicable for this study.
: No human subjects and no patient-level data were used in this study therefore consent for publication is not applicable.
: Deirdre Weymann co-directs IMPRINT Research Consulting and has consulted for Roche Canada and Astra-Zeneca Canada. Dean A. Regier has received honoraria from Roche Canada and Astra-Zeneca. Brandon Chan has no competing interests to disclose.
